StonvexLoading…
StonvexStonvexStonvexCore line items from LAZ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.19B | $3.14B | $2.59B | $2.86B |
Operating Income | $327.60M | $386.47M | $-79.96M | $516.85M |
Net Income | $236.83M | $279.91M | $-75.48M | $357.52M |
EPS (Diluted) | $2.17 | $2.68 | $-0.90 | $3.51 |
Total Assets | $4.94B | $4.79B | $4.64B | $5.85B |
Total Liabilities | $3.95B | $4.03B | $4.07B | $4.59B |
Cash & Equivalents | $1.47B | $1.31B | $971.32M | $1.23B |
Free Cash Flow OCF − CapEx | $487.38M | $697.33M | $136.37M | $784.47M |
Shares Outstanding | 106.34M | 102.39M | 88.99M | 101.00M |